✦ LIBER ✦

Physiologically Based Pharmacokinetic Model Use in Risk Assessment--Why Being Published Is Not Enough

✍ Scribed by McLanahan, E. D.; El-Masri, H. A.; Sweeney, L. M.; Kopylev, L. Y.; Clewell, H. J.; Wambaugh, J. F.; Schlosser, P. M.

Book ID: 111878405
Publisher: Oxford University Press
Year: 2011
Tongue: English
Weight: 226 KB
Volume: 126
Category: Article
ISSN: 1096-6080
DOI: 10.1093/toxsci/kfr295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of physiologically based phar

Evaluation of physiologically based pharmacokinetic models for use in risk assessment

✍ Weihsueh A. Chiu; Hugh A. Barton; Robert S. DeWoskin; Paul Schlosser; Chad M. Th 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract Physiologically based pharmacokinetic (PBPK) models are sophisticated dosimetry models that offer great flexibility in modeling exposure scenarios for which there are limited data. This is particularly of relevance to assessing human exposure to environmental toxicants, which often requ

Development and specification of physiol

Development and specification of physiologically based pharmacokinetic models for use in risk assessment

✍ Rebecca A. Clewell; Harvey J. Clewell III 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Framework for Evaluation of Physiologica

Framework for Evaluation of Physiologically-Based Pharmacokinetic Models for Use in Safety or Risk Assessment

✍ Leona H. Clark; R. Woodrow Setzer; Hugh A. Barton 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 229 KB

A Trichloroethylene Risk Assessment Usin

A Trichloroethylene Risk Assessment Using a Monte Carlo Analysis of Parameter Uncertainty in Conjunction with Physiologically-Based Pharmacokinetic Modeling

✍ William J. Cronin IV; Eric J. Oswald; Michael L. Shelley; Jeffrey W. Fisher; Car 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 859 KB

081030 (M10, B20) A tricholoethylene ris

081030 (M10, B20) A tricholoethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling: Cronin W.J., Oswald E.J., Shelley M.L., Fisher J.W., Flemming C.D., Risk Analysis, Vol. 15, Number 5, 1995, pp. 555–565

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Renal insufficiency and anemia are indep

Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction1,21As published material, the contents of this manuscript may not be cited, quoted, reproduced or published without the consent of the authors.2The analyses upon which this publication is based were performed under Contract Number 500-96-P704, entitled âOperation Utilization and Quality Control Peer Review Organization (PRO) for the State of Georgiaâ and sponsored by the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services. The conclusions and opinions expressed, and methods used herein are those of the authors. They do not necessarily reflect CMS policy. The authors assume full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by CMS, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this Contractor. Ideas and contributions to the authors concerning experience in engaging with issues presented are welcomed.

✍ Langston, Robert D.; Presley, Rodney; Flanders, W. Dana; Mcclellan, William M. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 373 KB